This trial is to study a new mitral valve repair system in patients who are at high risk for conventional mitral valve surgery.
1 Primary · 4 Secondary · Reporting Duration: 30 Days (+ annually through 5 years)
1 Treatment Group
Half Moon TMVr System
1 of 1
30 Total Participants · 1 Treatment Group
Primary Treatment: Half Moon TMVr System · No Placebo Group · N/A
Who is running the clinical trial?
Age 21 - 95 · All Participants · 7 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
To whom is enrollment in this clinical experiment available?
"Eligibility requirements to join this trial include having a diagnosis of mitral valve insufficiency and being between 21-95 years old. Currently, the research team is seeking 30 participants in total." - Anonymous Online Contributor
What is the current enrollment size of this research trial?
"Affirmative. Clinicaltrials.gov reports that this study, which was first posted on December 8th 2020, is actively seeking participants. 30 individuals are required to be recruited from only one medical centre." - Anonymous Online Contributor
Is this clinical investigation open to participants who are of legal age?
"Eligibility for this trial is determined by the patient's age, with those over 21 and less than 95 years old being able to participate." - Anonymous Online Contributor
Are there any opportunities for individuals to participate in this research project?
"Information hosted on clinicaltrials.gov confirms that this healthcare trial is still allocating participants. The study was initially posted on December 8th 2020 and the data was most recently modified on March 15th 2022." - Anonymous Online Contributor